Xconomy

NOVEMBER 11, 2016

—Oral arguments in the landmark patent fight over ownership of the gene editing technology CRISPR-Cas9 were set for Dec. Patent and Trademark Office. —Despite the patent fight, CRISPR work continues apace. —Despite the patent fight, CRISPR work continues apace. The Nitto drug is in a Phase 1b study.

Patents 87

Patents Study Pricing Research 87

InfoChachkie

OCTOBER 24, 2011

According to financial columnist Daniel Solin, “One large study looked at more than 15,000 predictions by 237 market timing newsletters over a 12-year period. At the end of the period studied, 94.5% Watson, IBM Founder. of the newsletters went bust.”. Phoenix Effect. “If If you want to succeed, double your failure rate.”.

Company 257

Company Companies Startup Study 257

Xconomy

MAY 30, 2016

Lita Nelsen has seen it up close—and played a part in its evolution—from her studies there in the 1960s, to her business-school fellowship in the late 1970s, to her 30 years working in MIT’s Technology Licensing Office. MIT’s approach to nurturing entrepreneurship has changed a lot over the past 50 years.

Startup 67

Startup Compton Research Technology 67